Fertility and Sterility
Volume 88, Issue 2 , Pages 350-353, August 2007

Comparison of FSH flare with and without pretreatment with oral contraceptive pills in poor responders undergoing in vitro fertilization

Presented at the 59th Annual Meeting of the American Society for Reproductive Medicine, San Antonio, Texas, October 11–15, 2003.

  • Martin D. Keltz, M.D.

      Affiliations

    • Corresponding Author InformationReprint requests: Martin D. Keltz, M.D., Director, Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, St. Luke’s Roosevelt Hospital Center, 425 West 59th Street, Suite 5A, New York, NY 10019 (FAX: 212-523-8348).
  • ,
  • Puja S. Gera, M.D.
  • ,
  • Josh Skorupski, M.D.
  • ,
  • Daniel E. Stein, M.D.

Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, St. Luke’s Roosevelt Hospital Center, Columbia University College of Physicians and Surgeons, New York, New York

Received 15 May 2006; received in revised form 21 November 2006; accepted 21 November 2006.

Objective

To compare FSH, LH, estrogen, and P flare response following 1 mg lupron injection in poor responders with or without pretreatment with oral contraceptive pills (OCPs).

Design

Prospective study.

Setting

University hospital.

Patient(s)

Poor responders undergoing IVF flare protocol from October 2002 to November 2003.

Intervention(s)

Patients were divided into group A, who received OCPs before IVF cycle (n = 12), and group B, who did not (n = 7). One milligram Lupron was injected SC after measuring day 2 serum FSH, LH, estrogen, and P. After 24 hours, serum hormones were measured before lupron administration.

Main outcome measure(s)

Serum FSH, LH, estrogen, and P before and after 1 mg lupron

Result(s)

Basal FSH was similar in both groups (8.6 ± 4.5 vs. 9.6 ± 2.9 mIU/mL). Group A patients had significantly lower day 2 FSH (3.6 ± 3.6 vs. 10.1 ± 4.2 mIU/mL; P<.05). After lupron, although both groups had a significant rise in FSH and LH, mean LH rise in group B was 39.5 ± 31 mIU/mL versus 11.3 ± 4.6 mIU/mL in group A (P<.05).

Conclusion(s)

Pretreatment with OCPs in GnRH agonist flare protocol suppresses pre-Lupron FSH but does not blunt FSH flare. It blunts LH flare, which may be beneficial.

Key Words: Oral contraceptive pills, flare protocol, poor responders

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0015-0282(06)04657-7

doi:10.1016/j.fertnstert.2006.11.123

Fertility and Sterility
Volume 88, Issue 2 , Pages 350-353, August 2007